UAS regulatory sequences drive expression of a full-length, pathogenic form of Hsap\ATXN3 (has a polyglutamine repeat of 77-80 residues) with a W87A mutation in Ubiquitin-binding site 2 (UbS2) that mildly disrupts binding to Rad23 protein.